Eurofins Discovery provides integrated medicinal chemistry services and drug discovery chemistry solutions designed to accelerate hit-to-lead and lead optimization programs. As a global medicinal chemistry CRO, we combine synthetic, computational, and AI-assisted chemistry to shorten DMTA cycles and deliver decision-ready data faster.
Supporting early discovery through IND-enabling stages, our teams help biotech and pharma companies move from concept to clinic with confidence.
Why Choose Eurofins Discovery for Medicinal Chemistry
- 300+ chemists across the US, UK, Europe, and India
- 600+ drug discovery experts across biology, ADME, and analytics
- AI-assisted molecular design and prioritization
- High-throughput and parallel synthesis capabilities
- mg-to-kg scalable chemistry for seamless program progression
- Fully integrated with ADME-PK, screening, and biology teams
Start your chemistry program with a custom proposal
The Chemistry Engine Behind Modern Drug Discovery
Our platform integrates medicinal chemistry, synthetic chemistry, and computational chemistry into a unified DMTA workflow.
We design, make, test, and optimize compounds faster, so your team can make better decisions sooner.
Unlike traditional fragmented CRO models, Eurofins Discovery connects chemistry directly with biology, screening, and ADME-PK services, reducing delays and improving data consistency across your program.
1. Hit Identification & Early Design (Design Faster & Smarter)
Capabilities
- AI-driven compound prioritization
- Computational chemistry and modeling
- Rapid and parallel synthesis
- High-throughput experimentation (HTE)
- Fast SAR generation and interpretation
Outcomes
Shorter design cycles, faster hypothesis testing, and stronger scientific rationale for internal teams and investors.
Ideal For
Early-stage biotech, academic spin-offs, and AI-driven drug discovery companies.
2. Hit-to-Lead & Lead Optimization Programs
Capabilities
- Integrated medicinal and computational chemistry
- Compound synthesis, purification, and analytical support
- Direct integration with ADME-PK and screening assays
- Dedicated scientific program management
Outcomes
Reduced CRO fragmentation, synchronized workflows, and consistent timelines (typically 6–18 months) with decision-ready data packages.
Ideal For
Growing biotech companies preparing for key development milestones.
3. Advanced Chemistry, Complex Modalities & Scale-Up
Capabilities
- Complex synthetic route design and optimization
- Macrocycles, peptides, PROTACs, and molecular glues
- ADC payload and linker chemistry
- Route scouting and process rescue
- Gram-to-kilogram scale synthesis
Outcomes
Reliable compound supply, robust documentation, and minimized delays for downstream studies and IND-enabling work.
Ideal For
Pharma and late-stage biotech programs requiring scalability and technical depth.
Comparative Overview of Our Chemistry Service Tiers
| Stage | Early Discovery | Integrated Programs | Advanced & Scale-Up |
|---|---|---|---|
| Primary Focus | Rapid design & iteration | End-to-end program execution | Complex chemistry & scale |
| Capabilities | AI design, HTE, SAR | Full DMTA integration | Advanced modalities & scale |
| Outcomes | Faster learning cycles | Decision-ready data | Reliable supply & documentation |
| Typical Start | Pilot design loop | Program onboarding | Route scouting or pilot batch |
Integrated Drug Discovery Chemistry Within a Full Ecosystem
Our chemistry teams work seamlessly with:
- Biology & screening to validate targets and compounds
- ADME-PK services to evaluate drug-like properties
- Analytical sciences to ensure data quality and reproducibility
This integrated approach reduces handoffs, accelerates timelines, and improves overall program success rates.
Technologies Powering Our Chemistry Platform
AI-Assisted Molecular Design
Machine learning models prioritize compounds before synthesis, improving efficiency, and reducing unnecessary iterations.
High-Throughput Experimentation (HTE)
Parallel chemistry techniques enable rapid exploration of chemical space and faster SAR development.
Advanced Analytical Sciences
NMR, LC-MS, SFC, and HPLC ensure structural confirmation, purity, and regulatory-ready data.
Global Chemistry Capacity
With laboratories across the US, UK, Europe, and India, we offer scalable capacity and a follow-the-sun model to accelerate timelines.
Modalities Supported
We support a wide range of therapeutic modalities, including:
- Small molecules
- PROTACs and molecular glues
- Peptides and macrocycles
- ADC payloads and linker chemistry
Proven Experience in Medicinal Chemistry Programs
Eurofins Discovery supports hundreds of discovery programs annually, delivering:
- Rapid hit-to-lead progression
- Optimized lead candidates for development
- Scalable synthesis for preclinical studies
Our teams bring deep expertise across therapeutic areas and complex chemistry challenges, helping reduce risk and accelerate outcomes.
FAQs About Medicinal Chemistry Services
What does a medicinal chemistry CRO do?
A medicinal chemistry CRO designs, synthesizes, and optimizes compounds to support hit-to-lead and lead optimization stages of drug discovery.
How do medicinal chemistry services accelerate drug discovery?
They increase synthesis capacity, provide specialized expertise, and streamline DMTA cycles to reduce timelines and improve decision-making.
Do you support complex modalities like PROTACs and ADCs?
Yes. We support macrocycles, peptides, degraders, and ADC payload and linker chemistry.
What is the best way to start a chemistry program?
Most programs begin with a pilot phase such as a design loop, SAR sprint, or route scouting study to validate approach and timelines.
Start Your Medicinal Chemistry Program
Whether you need rapid design support, full program execution, or complex chemistry scale-up, Eurofins Discovery can help.
